The China’s NMPA Grants Approval to Genesis Medtech's Articulation Powered Stapler, iReach Omnia, for Complex Surgeries
Shots:
- The NMPA has approved iReach Omnia for market release, enhancing precision and access in complex laparoscopic surgeries
- The iReach Omnia transforms surgical stapling with 90° articulation, offering precision and maneuverability in confined spaces. It minimizes staple line weak points, reduces anastomotic leakage risks & enhances outcomes in complex procedures like colorectal and thoracic surgeries
- The device also addresses the challenges of traditional surgical staplers having 45°–60° articulation angles that becomes limitation in complex procedures like low anterior resection, requiring greater flexibility for restricted anatomical access
Ref: Prnewswire | Image: Genesis Medtech
Related News:- Inogen Secures the US FDA’s Clearance for SIMEOX 200 Airway Clearance Device
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
